2015/10/08 by By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel · 3 citations
Medicine · Economics, Econometrics and Finance · #Pharmaceutical Practices and Patient Outcomes #Health Systems, Economic Evaluations, Quality of Life #Palliative Care and End-of-Life Issues
paper · doi:10.1111/jgs.13702
openalex publication_date 2015/10/08 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28
The 2015 American Geriatrics Society (AGS) Beers Criteria are presented. Like the 2012 AGS Beers Criteria, they include lists of potentially inappropriate medications to be avoided in older adults. New to the criteria are lists of select drugs that should be avoided or have their dose adjusted based on the individual's kidney function and select drug-drug interactions documented to be associated with harms in older adults. The specific aim was to have a 13-member interdisciplinary panel of experts in geriatric care and pharmacotherapy update the 2012 AGS Beers Criteria using a modified Delphi method to systematically review and grade the evidence and reach a consensus on each existing and new criterion. The process followed an evidence-based approach using Institute of Medicine standards. The 2015 AGS Beers Criteria are applicable to all older adults with the exclusion of those in palliative and hospice care. Careful application of the criteria by health professionals, consumers, payors, and health systems should lead to closer monitoring of drug use in older adults.